仲村　秀太 (ナカムラ　ヒデタ)

Nakamura Hideta

写真a

職名

助教

ホームページ

https://www.ryukyu-med1.com/

このページの先頭へ▲

現在の所属組織 【 表示 ／ 非表示 】

  • 専任   琉球大学   医学研究科   助教  

このページの先頭へ▲

出身大学 【 表示 ／ 非表示 】

  • 1997年04月
    -
    2003年03月

    琉球大学   医学部   医学科   卒業

このページの先頭へ▲

留学歴 【 表示 ／ 非表示 】

  • 2016年04月
    -
    2018年03月

    Imperial College London  

このページの先頭へ▲

取得学位 【 表示 ／ 非表示 】

  • 琉球大学 -  博士（医学）  ライフサイエンス / 感染症内科学

このページの先頭へ▲

論文 【 表示 ／ 非表示 】

  • Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19

    Hideta Nakamura, Takeshi Kinjo, Wakako Arakaki, Kazuya Miyagi, Masao Tateyama, Jiro Fujita

    Critical Care ( Springer )  24 ( 1 ) 484 - 484   2020年08月 [ 査読有り ]

    掲載種別: 研究論文（学術雑誌）

  • Late diagnosis of HIV in 2022: Why so little change?

    Collins S, Namiba A, Sparrowhawk A, Strachan S, Thompson M, Nakamura H

    HIV medicine ( HIV Medicine )  23 ( 11 ) 1118 - 1126   2022年12月 [ 査読有り ]

    掲載種別: 研究論文（学術雑誌）

    　概要を見る

    Background: The proportion of people who are diagnosed late is a key metric to measure the public health response to HIV. But this percentage remains stubbornly high in nearly every country. Delays in accessing antiretroviral therapy affects both (i) individual health, due to a higher risk of mortality, and (ii) population-based health, due to continued risk of transmission. Despite huge efforts to increase testing, late diagnosis continues to be an indication of a public health failure. Outline: This short review includes community perspectives on why late diagnosis continues and how it may be reduced. We discuss both structural barriers that prevent people from testing earlier and personal reasons why some people still refuse testing when offered. We note that late diagnosis is reported in all countries and in all demographic groups and that sex, gender, age, and sexuality all affect these rates. However, even in groups with high HIV awareness, such as in gay and bisexual men in the UK, more than one in three people with HIV continue to be diagnosed late. Fears and prejudice about HIV based on outdated information are still common among both health workers and people using health services. For example, testing is still not offered in primary or emergency care settings, and even free testing might not be accepted if someone fears the outcome might jeopardize their resident status, employment, relationship, or health. Summary: In addition to developing targeted projects to reach the highest-risk groups, a positive mainstream public campaign could make testing more acceptable at a broad population level across all demographics. This could challenge and repair the media campaigns from the 1980s that still contribute to the stigma that frightens people away from testing now. We hope that an effective approach in one country might also help others.

    • この論文にアクセスする
      DOI
    • 関連情報を調べる
      PubMed

  • Mpox in people with HIV: A narrative review

    Hideta Nakamura, Kazuko Yamamoto

    HIV Medicine ( Wiley )    2024年05月 [ 査読有り ]

    掲載種別: 研究論文（学術雑誌）

    　概要を見る

    Objective: The 2022 global mpox outbreak disproportionately impacted people living with HIV. This review explores recent evidence on mpox in this group, focusing on clinical presentation, complications, treatment modalities and vaccine strategies. Recent findings: Recent studies have suggested that people with HIV diagnosed with mpox have a greater risk of proctitis and hospitalization compared with people without HIV. In addition, those with advanced immunosuppression face an elevated risk of severe mpox infection, which can lead to mortality. Comprehensive and prompt supportive care using antiretrovirals and mpox antivirals is crucial in this group. Although results from randomized clinical trials are still forthcoming, recent studies suggest that early initiation of tecovirimat can prevent disease progression in people with HIV. The non-replicative attenuated smallpox vaccine is well tolerated and effective in preventing monkeypox virus infections in people with HIV. Further studies are needed regarding long-term vaccine effectiveness for this population. Conclusion: Evaluating the risk of severe mpox in people living with HIV requires assessing the level of immune suppression and viral control. Universal access to vaccination is imperative to prevent the resurgence of future outbreaks.

  • 特集 十二指腸・小腸疾患アトラス Ⅱ.炎症性疾患 感染症:細菌性 非結核性抗酸菌による十二指腸・小腸炎

    伊良波 淳, 仲村 秀太, 玉城 智子, 金城 徹, 山本 和子

    消化器内視鏡 ( 東京医学社 )  36 ( 4 ) 564 - 565   2024年04月

    掲載種別: 研究論文（学術雑誌）

  • 特集 その知見は臨床を変える?-エキスパートが解説! 内科における最新論文 感染症 HIV感染症の治療と予防(PrEP)-プライマリ・ケアでも治療できるHIV診療の新時代

    仲村 秀太

    medicina ( 株式会社医学書院 )  61 ( 1 ) 69 - 74   2024年01月

    掲載種別: 研究論文（学術雑誌）

全件表示 >>

このページの先頭へ▲

科研費獲得情報 【 表示 ／ 非表示 】

  • 腸内細菌叢異常はHIV感染者の認知フレイル発症を加速させるのか？

    基盤研究(C)

    課題番号: 24K10556

    研究期間: 2024年04月  -  継続中 

    代表者: 仲村秀太 

このページの先頭へ▲